Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

Zhongren Zhou1 Department of Pathology & Immunology, Washington University, Saint Louis, MO, USACorrespondence[email protected]

Irina Kalatskaya2 Department of Adaptive Oncology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada

Donna Russell1 Department of Pathology & Immunology, Washington University, Saint Louis, MO, USA

Norman Marcon3 Division of Gastroenterology, Department of Internal Medicine, St. Michael’s Hospital, Toronto, Ontario, Canada

Maria Cirocco3 Division of Gastroenterology, Department of Internal Medicine, St. Michael’s Hospital, Toronto, Ontario, Canada

Paul M Krzyzanowski2 Department of Adaptive Oncology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada

Cathy Streutker3 Division of Gastroenterology, Department of Internal Medicine, St. Michael’s Hospital, Toronto, Ontario, Canada

Hua Liang4 Department of Statistics, George Washington University, Washington, DC, USA

Virginia R Litle5 Department of Surgery, Boston University School of Medicine, Boston, MA, USA

Tony E Godfrey5 Department of Surgery, Boston University School of Medicine, Boston, MA, USA

Lincoln Stein2 Department of Adaptive Oncology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada

Your download is now in progress and you may close this window